Sage Therapeutics CEO: Getting the first postpartum depression drug approved

7:05 PM ET Wed, 20 March 2019

Jim Cramer talks with Sage Therapeutics CEO Jeff Jonas about the biopharma company's Zulresso drug for postpartum depression and how it could help mothers.